AZYMAB Trademark

Trademark Overview

On Friday, July 12, 2013, a trademark application was filed for AZYMAB with the United States Patent and Trademark Office. The USPTO has given the AZYMAB trademark a serial number of 86009222. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, October 9, 2019. This trademark is owned by Zymeworks Inc.. The AZYMAB trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Therapeutic, prophylactic preparations, and pharmaceutical products and agents for the treatment or prophylaxis of human diseases, disorders and conditions, namely, cancer, autoimmune and inflammatory diseases

Scientific research and development of preparations, agents and technology for the development of antibody therapeutics all for the treatment and prophylaxis of human diseases, disorders and conditions, namely, cancer, autoimmune and inflammatory diseases; providing scientific information to scientists, physicians and health care providers in the field of cancer, autoimmune diseases, inflammatory diseases, and infectious diseases

Licensing of proprietary intellectual property
azymab

General Information

Serial Number86009222
Word MarkAZYMAB
Filing DateFriday, July 12, 2013
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, October 9, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesTherapeutic, prophylactic preparations, and pharmaceutical products and agents for the treatment or prophylaxis of human diseases, disorders and conditions, namely, cancer, autoimmune and inflammatory diseases
Goods and ServicesScientific research and development of preparations, agents and technology for the development of antibody therapeutics all for the treatment and prophylaxis of human diseases, disorders and conditions, namely, cancer, autoimmune and inflammatory diseases; providing scientific information to scientists, physicians and health care providers in the field of cancer, autoimmune diseases, inflammatory diseases, and infectious diseases
Goods and ServicesLicensing of proprietary intellectual property

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 20, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 20, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 21, 2014
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZymeworks Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBritish Columbia V6H3V9
CA

Trademark Events

Event DateEvent Description
Wednesday, October 9, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, October 9, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, March 13, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, March 13, 2019INQUIRY TO SUSPENSION E-MAILED
Wednesday, March 13, 2019SUSPENSION INQUIRY WRITTEN
Tuesday, March 12, 2019LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, August 31, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, August 31, 2018LETTER OF SUSPENSION E-MAILED
Friday, August 31, 2018SUSPENSION LETTER WRITTEN
Monday, August 20, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 20, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 6, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, February 28, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, February 28, 2018INQUIRY TO SUSPENSION E-MAILED
Wednesday, February 28, 2018SUSPENSION INQUIRY WRITTEN
Monday, February 26, 2018LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, August 15, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 15, 2017LETTER OF SUSPENSION E-MAILED
Tuesday, August 15, 2017SUSPENSION LETTER WRITTEN
Tuesday, August 1, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 1, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 28, 2017ASSIGNED TO LIE
Monday, June 26, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, December 31, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Saturday, December 31, 2016INQUIRY TO SUSPENSION E-MAILED
Saturday, December 31, 2016SUSPENSION INQUIRY WRITTEN
Thursday, December 29, 2016LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, June 29, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, June 29, 2016LETTER OF SUSPENSION E-MAILED
Wednesday, June 29, 2016SUSPENSION LETTER WRITTEN
Friday, June 17, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 17, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 9, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, December 18, 2015NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, December 18, 2015INQUIRY TO SUSPENSION E-MAILED
Friday, December 18, 2015SUSPENSION INQUIRY WRITTEN
Thursday, December 17, 2015LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, June 12, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, June 12, 2015LETTER OF SUSPENSION E-MAILED
Friday, June 12, 2015SUSPENSION LETTER WRITTEN
Wednesday, May 27, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 27, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 22, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, November 27, 2014NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, November 27, 2014INQUIRY TO SUSPENSION E-MAILED
Thursday, November 27, 2014SUSPENSION INQUIRY WRITTEN
Friday, November 21, 2014LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, May 21, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, May 21, 2014LETTER OF SUSPENSION E-MAILED
Wednesday, May 21, 2014SUSPENSION LETTER WRITTEN
Wednesday, May 21, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 21, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 13, 2014ASSIGNED TO LIE
Monday, April 28, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 29, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 29, 2013NON-FINAL ACTION E-MAILED
Tuesday, October 29, 2013NON-FINAL ACTION WRITTEN
Thursday, October 24, 2013ASSIGNED TO EXAMINER
Saturday, July 20, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 16, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

azymab diseases autoimmune cancer inflammatory disorders namely development scientific conditions agents